Colorectal Cancer News
New Clinical Trial for Unresectable Liver Metastases Now Recruiting
November 17, 2011
A new Phase I clinical trial titled TKM-080301: For Primary or Secondary Liver Cancer, is now recruiting. Although the title focuses on liver cancer, the trial is for those with unresectable liver metastases from numerous tumors (secondary), including those with colorectal cancer. The trial utilizes a new nanoparticle technology that delivers the experimental drug directly into the liver tumor. All participants will be given the drug. To find out if you are eligible, call the Colon Cancer Alliance’s Clinical Trial Matching Service: (866)278-0392 and ask for information by the ID number (NCT01437007) or the trial title (TKM-080301: For Primary or Secondary Liver Cancer).